Detalhe da pesquisa
1.
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine.
Proc Natl Acad Sci U S A
; 116(43): 21780-21788, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591215
2.
Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli.
Microb Cell Fact
; 16(1): 68, 2017 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28438207
3.
MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action.
J Immunol
; 188(7): 3088-98, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22351935
4.
Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines.
Proc Natl Acad Sci U S A
; 108(24): 9969-74, 2011 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21628568
5.
Human heat shock protein (Hsp) 90 interferes with Neisseria meningitidis adhesin A (NadA)-mediated adhesion and invasion.
Cell Microbiol
; 14(3): 368-85, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22066472
6.
Bacterial Outer Membrane Vesicles as a Platform for the Development of a Broadly Protective Human Papillomavirus Vaccine Based on the Minor Capsid Protein L2.
Vaccines (Basel)
; 11(10)2023 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37896984
7.
Immunogenicity of Escherichia coli Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens.
Membranes (Basel)
; 13(11)2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37999368
8.
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles.
Cancers (Basel)
; 15(13)2023 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444437
9.
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine.
Res Sq
; 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37292970
10.
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine.
Vaccines (Basel)
; 11(10)2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37896949
11.
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells.
Front Oncol
; 12: 912639, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35847919
12.
Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The Staphylococcus aureus Case.
Front Immunol
; 12: 752168, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34819933
13.
Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines.
Vaccines (Basel)
; 9(11)2021 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34835287
14.
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform.
J Extracell Vesicles
; 10(4): e12066, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33643549
15.
Vaccination With a FAT1-Derived B Cell Epitope Combined With Tumor-Specific B and T Cell Epitopes Elicits Additive Protection in Cancer Mouse Models.
Front Oncol
; 8: 481, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30416985
16.
Synergistic Protective Activity of Tumor-Specific Epitopes Engineered in Bacterial Outer Membrane Vesicles.
Front Oncol
; 7: 253, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29164053
17.
Role of ARF6, Rab11 and external Hsp90 in the trafficking and recycling of recombinant-soluble Neisseria meningitidis adhesin A (rNadA) in human epithelial cells.
PLoS One
; 9(10): e110047, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25347845
18.
Rational design of small molecules as vaccine adjuvants.
Sci Transl Med
; 6(263): 263ra160, 2014 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25411473
19.
Vaccine adjuvants: mode of action.
Front Immunol
; 4: 214, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23914187